Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.

Chinnadurai R, Copland IB, Patel SR, Galipeau J.

J Immunol. 2014 Feb 15;192(4):1491-501. doi: 10.4049/jimmunol.1301828. Epub 2014 Jan 8.

PMID:
24403533
[PubMed - indexed for MEDLINE]
2.

EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Nguyen TM, Arthur A, Hayball JD, Gronthos S.

Stem Cells Dev. 2013 Oct 15;22(20):2751-64. doi: 10.1089/scd.2012.0676. Epub 2013 Jun 29.

PMID:
23711177
[PubMed - indexed for MEDLINE]
3.

Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

Tipnis S, Viswanathan C, Majumdar AS.

Immunol Cell Biol. 2010 Nov-Dec;88(8):795-806. doi: 10.1038/icb.2010.47. Epub 2010 Apr 13.

PMID:
20386557
[PubMed - indexed for MEDLINE]
4.

Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.

Cuerquis J, Romieu-Mourez R, François M, Routy JP, Young YK, Zhao J, Eliopoulos N.

Cytotherapy. 2014 Feb;16(2):191-202. doi: 10.1016/j.jcyt.2013.11.008.

PMID:
24438900
[PubMed - indexed for MEDLINE]
5.

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D.

Blood. 2004 Jun 15;103(12):4619-21. Epub 2004 Mar 4.

PMID:
15001472
[PubMed - indexed for MEDLINE]
Free Article
6.

Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.

Pfeifer S, Schreder M, Bolomsky A, Graffi S, Fuchs D, Sahota SS, Ludwig H, Zojer N.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1821-30. doi: 10.1007/s00432-012-1259-2. Epub 2012 Jun 22.

PMID:
22722711
[PubMed - indexed for MEDLINE]
7.

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

François M, Romieu-Mourez R, Li M, Galipeau J.

Mol Ther. 2012 Jan;20(1):187-95. doi: 10.1038/mt.2011.189. Epub 2011 Sep 20.

PMID:
21934657
[PubMed - indexed for MEDLINE]
8.

Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.

Lin W, Oh SK, Choo AB, George AJ.

Cytotherapy. 2012 Mar;14(3):274-84. doi: 10.3109/14653249.2011.635853. Epub 2011 Dec 5.

PMID:
22136295
[PubMed - indexed for MEDLINE]
9.

Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells.

Selleri S, Dieng MM, Nicoletti S, Louis I, Beausejour C, Le Deist F, Haddad E.

Stem Cells Dev. 2013 Apr 1;22(7):1063-75. doi: 10.1089/scd.2012.0315. Epub 2013 Jan 4.

PMID:
23167734
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.

English K, Barry FP, Field-Corbett CP, Mahon BP.

Immunol Lett. 2007 Jun 15;110(2):91-100. Epub 2007 Apr 26.

PMID:
17507101
[PubMed - indexed for MEDLINE]
11.

Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.

DelaRosa O, Lombardo E, Beraza A, Mancheño-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, García L, Abad JL, Trigueros C, Delgado M, Büscher D.

Tissue Eng Part A. 2009 Oct;15(10):2795-806. doi: 10.1089/ten.TEA.2008.0630.

PMID:
19231921
[PubMed - indexed for MEDLINE]
12.

Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.

Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, Rabson AB, Roberts AI, Wang Y, Shi Y.

Cancer Res. 2014 Mar 1;74(5):1576-87. doi: 10.1158/0008-5472.CAN-13-1656. Epub 2014 Jan 22.

PMID:
24452999
[PubMed - indexed for MEDLINE]
13.

Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis.

Hsu WT, Lin CH, Chiang BL, Jui HY, Wu KK, Lee CM.

J Immunol. 2013 Mar 1;190(5):2372-80. doi: 10.4049/jimmunol.1202996. Epub 2013 Jan 28.

PMID:
23359497
[PubMed - indexed for MEDLINE]
Free Article
14.

Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.

Stubbendorff M, Deuse T, Hua X, Phan TT, Bieback K, Atkinson K, Eiermann TH, Velden J, Schröder C, Reichenspurner H, Robbins RC, Volk HD, Schrepfer S.

Stem Cells Dev. 2013 Oct 1;22(19):2619-29. doi: 10.1089/scd.2013.0043. Epub 2013 Jun 29.

PMID:
23711207
[PubMed - indexed for MEDLINE]
15.

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB.

PLoS One. 2010 Feb 2;5(2):e9016. doi: 10.1371/journal.pone.0009016.

PMID:
20126406
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S.

Stem Cells Dev. 2010 May;19(5):693-706. doi: 10.1089/scd.2009.0365.

PMID:
20067407
[PubMed - indexed for MEDLINE]
17.

Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.

Pradier A, Passweg J, Villard J, Kindler V.

Cell Transplant. 2011;20(5):681-91. doi: 10.3727/096368910X536545. Epub 2010 Nov 5.

PMID:
21054933
[PubMed - indexed for MEDLINE]
18.

Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase.

Jui HY, Lin CH, Hsu WT, Liu YR, Hsu RB, Chiang BL, Tseng WY, Chen MF, Wu KK, Lee CM.

Cell Transplant. 2012;21(5):971-84. doi: 10.3727/096368911X627525. Epub 2012 Mar 22.

PMID:
22449499
[PubMed - indexed for MEDLINE]
19.
20.

Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

Colvin BL, Sumpter TL, Tokita D, Salati J, Mellor AL, Thomson AW.

Hum Immunol. 2009 May;70(5):313-20. doi: 10.1016/j.humimm.2009.01.021. Epub 2009 Feb 3.

PMID:
19208362
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk